Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Raw Materials (2020 - 2025)

Beauty Health (SKIN) has disclosed Raw Materials for 6 consecutive years, with $23.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Raw Materials fell 12.79% to $23.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $23.0 million, a 12.79% decrease, with the full-year FY2024 number at $26.0 million, up 6.61% from a year prior.
  • Raw Materials was $23.0 million for Q3 2025 at Beauty Health, roughly flat from $23.0 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $40.0 million in Q1 2023 to a low of $11.7 million in Q3 2021.
  • A 5-year average of $24.3 million and a median of $23.9 million in 2024 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: skyrocketed 219.14% in 2022, then crashed 40.57% in 2024.
  • Beauty Health's Raw Materials stood at $12.0 million in 2021, then surged by 219.14% to $38.4 million in 2022, then plummeted by 36.4% to $24.4 million in 2023, then increased by 6.61% to $26.0 million in 2024, then fell by 11.6% to $23.0 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Raw Materials are $23.0 million (Q3 2025), $23.0 million (Q2 2025), and $24.2 million (Q1 2025).